ARCANA INSTITUTE

A CERTARA COMPANY

Arcana Institute (INAR) is now part of Certara, a global leader in model-informed drug development and regulatory science.

Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides support for drug development through the product’s full life cycle, from clinical trial planning & design, drug registration, Real World Data, strategic support in HEOR and Market Access, up to reimbursement and beyond.

Certara’s staff includes over 700 experts in more than 20 offices worldwide!

Together, we are creating innovative analytical methods to provide our partners with the highest-quality scientific evidence in safety, clinical efficacy and effectiveness for medical technologies.

find out more

Business Partners

Cooperative Institutions

News

12 November 2021

Analysis of the Reimbursement Decision-Making Practice in Poland (November 2021)

The results include the notice of the Minister of Health, effective 1st of November 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations  more...
13 September 2021

Analysis of the Reimbursement Decision-Making Practice in Poland (September 2021)

The results include the notice of the Minister of Health, effective 1st of September 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations  more...
16 July 2021

Analysis of the Reimbursement Decision-Making Practice in Poland (July 2021)

The results include the notice of the Minister of Health, effective 1st of July 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations  more...